MyFinsight
Home
About
Contact
avtx: the income statement
Download
Download image
Comprehensive (loss) income
-$30,550K
Unrealized income on
investments, net
$75K
Net (loss) income
-$30,625K
(-232.94%↓ Y/Y)
Income tax expense
(benefit)
$11K
(178.57%↑ Y/Y)
(loss) income before
taxes
-$30,614K
(-232.97%↓ Y/Y)
Total other (expense)
income, net
-$11,416K
(-131.81%↓ Y/Y)
Loss from operations
-$19,198K
(-49.27%↓ Y/Y)
Interest income, net
$1,117K
(15.87%↑ Y/Y)
Other expense, net
-$3K
(40.00%↑ Y/Y)
Change in fair value of
derivative liability
$12,530K
(1239.09%↑ Y/Y)
Total operating
expenses
$19,198K
(46.44%↑ Y/Y)
General and
administrative
$5,577K
(30.12%↑ Y/Y)
Research and development
$13,621K
(42.81%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX)